Theriva Biologics Inc. (TOVX) stock news · $12.4M cap
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
This TOVX news page leads with what Theriva Biologics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for TOVX yet. We will not pad this page with generic market recap.
Latest reported TOVX revenue for 2026-03-31 was $300.0K. Net income was -$2.0M. TOVX currently screens at market cap $12.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TOVX stock page; for the tape open the quote page.
TOVX stock news FAQ
What are TOVX's latest revenue and net income?
Latest cached Theriva Biologics Inc. (TOVX) revenue for Mar 31, 2026 was $300.0K. Net income was -$2.0M. Statements: https://lician.com/financials/tovx
What is TOVX's market cap?
Theriva Biologics Inc. (TOVX) market cap is $12.4M on the latest cached fundamentals snapshot.
What kind of company is TOVX?
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Where is TOVX stock news listed?
Cached stock news for Theriva Biologics Inc. (TOVX) is listed at https://lician.com/news/tovx. Filings: https://lician.com/sec/tovx
Not investment advice.